New cream aims to boost laser therapy results for vaginal atrophy
NCT ID NCT07346287
First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times
Summary
This study is testing whether a daily cream (7-0940®) can safely improve symptoms of vaginal atrophy in 10 women who have already completed laser therapy. Researchers will check vaginal health, quality of life, and any side effects over 45 days. The goal is to see if the cream helps recovery and symptom relief after laser treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATROPHIC VAGINITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Orange Coast Women's Medical Group
Laguna Hills, California, 92653, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gel ease menopause symptoms that disrupt daily life?
- Could a single injection ease vaginal dryness? new trial tests hyaluronic acid gel
- Blue light could soothe vaginal disorders without hormones
- Breast cancer survivors face hidden menopause burden
- Menopause symptom study pulled before enrolling a single patient
- Can vaginal estradiol or moisturizer ease menopause symptoms in women with HIV?